tiprankstipranks
Trending News
More News >
Icon plc (ICLR)
NASDAQ:ICLR
US Market

Icon (ICLR) Stock Forecast & Price Target

Compare
551 Followers
See the Price Targets and Ratings of:

ICLR Analyst Ratings

Moderate Buy
12Ratings
Moderate Buy
5 Buy
6 Hold
1 Sell
Based on 12 analysts giving stock ratings to
Icon
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

ICLR Stock 12 Month Forecast

Average Price Target

$121.00
▲(13.49% Upside)
Based on 12 Wall Street analysts offering 12 month price targets for Icon in the last 3 months. The average price target is $121.00 with a high forecast of $216.00 and a low forecast of $75.00. The average price target represents a 13.49% change from the last price of $106.62.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"74":"$74","217":"$217","109.75":"$109.8","145.5":"$145.5","181.25":"$181.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":216,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$216.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":121,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$121.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":75,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$75.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[74,109.75,145.5,181.25,217],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jun<br/>2025","6":"Sep<br/>2025","9":"Dec<br/>2025","12":"Mar<br/>2026","25":"Mar<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,108.27,116.55692307692307,124.84384615384616,133.13076923076923,141.4176923076923,149.70461538461538,157.99153846153845,166.27846153846156,174.56538461538463,182.8523076923077,191.13923076923078,199.42615384615385,207.71307692307693,{"y":216,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,108.27,109.24923076923076,110.22846153846153,111.2076923076923,112.18692307692308,113.16615384615385,114.14538461538461,115.12461538461538,116.10384615384615,117.08307692307692,118.06230769230768,119.04153846153847,120.02076923076923,{"y":121,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,108.27,105.71076923076923,103.15153846153846,100.59230769230768,98.03307692307692,95.47384615384615,92.91461538461539,90.35538461538462,87.79615384615384,85.23692307692308,82.67769230769231,80.11846153846153,77.55923076923077,{"y":75,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":190.02,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":166.56,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":145.21,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":128.9,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":148.88,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":166.44,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":177.84,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 44,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":192.31,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 46,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 24, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":171.82,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 41,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 25, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":179.71,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":182.22,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":178.59,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":108.27,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$216.00Average Price Target$121.00Lowest Price Target$75.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Citi
$200$120
Hold
12.55%
Upside
Reiterated
03/11/26
Icon price target lowered to $120 from $200 at CitiIcon price target lowered to $120 from $200 at Citi
Barclays Analyst forecast on ICLR
Barclays
Barclays
$200$120
Hold
12.55%
Upside
Reiterated
03/06/26
Icon price target lowered to $120 from $200 at BarclaysIcon price target lowered to $120 from $200 at Barclays
Jefferies Analyst forecast on ICLR
Jefferies
Jefferies
$135
Buy
26.62%
Upside
Upgraded
02/22/26
Icon plc: Valuation Overhang and Revenue Timing Issues Create Compelling Buy‑Rated Risk‑Reward Opportunity
TD Cowen
$183$120
Buy
12.55%
Upside
Upgraded
02/17/26
Icon plc: Accounting Probe Sell-Off Creates Compelling Value Despite Modest EPS Impact
Rothschild & Co Redburn Analyst forecast on ICLR
Rothschild & Co Redburn
Rothschild & Co Redburn
$226$100
Hold
-6.21%
Downside
Downgraded
02/17/26
Icon downgraded to Neutral from Buy at Rothschild & Co RedburnIcon downgraded to Neutral from Buy at Rothschild & Co Redburn
Truist Financial Analyst forecast on ICLR
Truist Financial
Truist Financial
Hold
Reiterated
02/17/26
Analysts Offer Insights on Healthcare Companies: CG Oncology, Inc. (NASDAQ: CGON), MiMedx Group (NASDAQ: MDXG) and Icon (NASDAQ: ICLR)
Robert W. Baird Analyst forecast on ICLR
Robert W. Baird
Robert W. Baird
$217$119
Buy
11.61%
Upside
Reiterated
02/13/26
Icon price target lowered to $119 from $217 at BairdIcon price target lowered to $119 from $217 at Baird
Leerink Partners Analyst forecast on ICLR
Leerink Partners
Leerink Partners
$105
Hold
-1.52%
Downside
Downgraded
02/12/26
Icon downgraded to Market Perform from Outperform at LeerinkIcon downgraded to Market Perform from Outperform at Leerink
Bank of America Securities Analyst forecast on ICLR
Bank of America Securities
Bank of America Securities
$195$75
Sell
-29.66%
Downside
Downgraded
02/12/26
Icon downgraded to Underperform from Neutral at BofAIcon downgraded to Underperform from Neutral at BofA
William Blair Analyst forecast on ICLR
William Blair
William Blair
Buy
Reiterated
02/12/26
Analysts Offer Insights on Healthcare Companies: Harrow Health (NASDAQ: HROW), Icon (NASDAQ: ICLR) and Perspective Therapeutics (NYSE MKT: CATX)
BMO Capital Analyst forecast on ICLR
BMO Capital
BMO Capital
$175$100
Hold
-6.21%
Downside
Reiterated
02/12/26
Icon price target lowered to $100 from $175 at BMO CapitalIcon price target lowered to $100 from $175 at BMO Capital
Mizuho Securities Analyst forecast on ICLR
Mizuho Securities
Mizuho Securities
$225$216
Buy
102.59%
Upside
Reiterated
01/09/26
Icon price target lowered to $216 from $225 at MizuhoIcon price target lowered to $216 from $225 at Mizuho
Evercore ISI
$220
Buy
106.34%
Upside
Reiterated
10/27/25
Evercore ISI Reaffirms Their Buy Rating on Icon (ICLR)
UBS
$240$220
Buy
106.34%
Upside
Reiterated
10/24/25
Icon price target lowered to $220 from $240 at UBSIcon price target lowered to $220 from $240 at UBS
J.P. Morgan Analyst forecast on ICLR
J.P. Morgan
J.P. Morgan
$175
Hold
64.13%
Upside
Reiterated
10/23/25
Analysts Conflicted on These Healthcare Names: BioNTech SE (NASDAQ: BNTX), Icon (NASDAQ: ICLR) and Innovent Biologics (Other OTC: IVBXF)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Citi
$200$120
Hold
12.55%
Upside
Reiterated
03/11/26
Icon price target lowered to $120 from $200 at CitiIcon price target lowered to $120 from $200 at Citi
Barclays Analyst forecast on ICLR
Barclays
Barclays
$200$120
Hold
12.55%
Upside
Reiterated
03/06/26
Icon price target lowered to $120 from $200 at BarclaysIcon price target lowered to $120 from $200 at Barclays
Jefferies Analyst forecast on ICLR
Jefferies
Jefferies
$135
Buy
26.62%
Upside
Upgraded
02/22/26
Icon plc: Valuation Overhang and Revenue Timing Issues Create Compelling Buy‑Rated Risk‑Reward Opportunity
TD Cowen
$183$120
Buy
12.55%
Upside
Upgraded
02/17/26
Icon plc: Accounting Probe Sell-Off Creates Compelling Value Despite Modest EPS Impact
Rothschild & Co Redburn Analyst forecast on ICLR
Rothschild & Co Redburn
Rothschild & Co Redburn
$226$100
Hold
-6.21%
Downside
Downgraded
02/17/26
Icon downgraded to Neutral from Buy at Rothschild & Co RedburnIcon downgraded to Neutral from Buy at Rothschild & Co Redburn
Truist Financial Analyst forecast on ICLR
Truist Financial
Truist Financial
Hold
Reiterated
02/17/26
Analysts Offer Insights on Healthcare Companies: CG Oncology, Inc. (NASDAQ: CGON), MiMedx Group (NASDAQ: MDXG) and Icon (NASDAQ: ICLR)
Robert W. Baird Analyst forecast on ICLR
Robert W. Baird
Robert W. Baird
$217$119
Buy
11.61%
Upside
Reiterated
02/13/26
Icon price target lowered to $119 from $217 at BairdIcon price target lowered to $119 from $217 at Baird
Leerink Partners Analyst forecast on ICLR
Leerink Partners
Leerink Partners
$105
Hold
-1.52%
Downside
Downgraded
02/12/26
Icon downgraded to Market Perform from Outperform at LeerinkIcon downgraded to Market Perform from Outperform at Leerink
Bank of America Securities Analyst forecast on ICLR
Bank of America Securities
Bank of America Securities
$195$75
Sell
-29.66%
Downside
Downgraded
02/12/26
Icon downgraded to Underperform from Neutral at BofAIcon downgraded to Underperform from Neutral at BofA
William Blair Analyst forecast on ICLR
William Blair
William Blair
Buy
Reiterated
02/12/26
Analysts Offer Insights on Healthcare Companies: Harrow Health (NASDAQ: HROW), Icon (NASDAQ: ICLR) and Perspective Therapeutics (NYSE MKT: CATX)
BMO Capital Analyst forecast on ICLR
BMO Capital
BMO Capital
$175$100
Hold
-6.21%
Downside
Reiterated
02/12/26
Icon price target lowered to $100 from $175 at BMO CapitalIcon price target lowered to $100 from $175 at BMO Capital
Mizuho Securities Analyst forecast on ICLR
Mizuho Securities
Mizuho Securities
$225$216
Buy
102.59%
Upside
Reiterated
01/09/26
Icon price target lowered to $216 from $225 at MizuhoIcon price target lowered to $216 from $225 at Mizuho
Evercore ISI
$220
Buy
106.34%
Upside
Reiterated
10/27/25
Evercore ISI Reaffirms Their Buy Rating on Icon (ICLR)
UBS
$240$220
Buy
106.34%
Upside
Reiterated
10/24/25
Icon price target lowered to $220 from $240 at UBSIcon price target lowered to $220 from $240 at UBS
J.P. Morgan Analyst forecast on ICLR
J.P. Morgan
J.P. Morgan
$175
Hold
64.13%
Upside
Reiterated
10/23/25
Analysts Conflicted on These Healthcare Names: BioNTech SE (NASDAQ: BNTX), Icon (NASDAQ: ICLR) and Innovent Biologics (Other OTC: IVBXF)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Icon

3 Months
xxx
Success Rate
25/41 ratings generated profit
61%
Average Return
+2.28%
upgraded a xxx
rating 18 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 60.98% of your transactions generating a profit, with an average return of +2.28% per trade.
1 Year
David WindleyJefferies
Success Rate
24/41 ratings generated profit
59%
Average Return
+2.19%
upgraded a buy rating 18 days ago
Copying David Windley's trades and holding each position for 1 Year would result in 58.54% of your transactions generating a profit, with an average return of +2.19% per trade.
2 Years
xxx
Success Rate
25/42 ratings generated profit
60%
Average Return
+6.00%
reiterated a xxx
rating 27 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 59.52% of your transactions generating a profit, with an average return of +6.00% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ICLR Analyst Recommendation Trends

Rating
Nov 25
Dec 25
Jan 26
Feb 26
Mar 26
Strong Buy
0
0
0
0
0
Buy
41
24
11
10
9
Hold
25
21
10
12
10
Sell
0
0
0
1
1
Strong Sell
0
0
0
0
0
total
66
45
21
23
20
In the current month, ICLR has received 9 Buy Ratings, 10 Hold Ratings, and 1 Sell Ratings. ICLR average Analyst price target in the past 3 months is 121.00.
Each month's total comprises the sum of three months' worth of ratings.

ICLR Financial Forecast

ICLR Earnings Forecast

Currently, no earnings data available.
Currently, no earnings data available.

ICLR Sales Forecast

Currently, no sales data available.
Currently, no sales data available.

ICLR Stock Forecast FAQ

What is ICLR’s average 12-month price target, according to analysts?
Based on analyst ratings, Icon plc’s 12-month average price target is 121.00.
    What is ICLR’s upside potential, based on the analysts’ average price target?
    Icon plc has 13.49% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is ICLR a Buy, Sell or Hold?
          Icon plc has a consensus rating of Moderate Buy which is based on 5 buy ratings, 6 hold ratings and 1 sell ratings.
            What is Icon plc’s price target?
            The average price target for Icon plc is 121.00. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $216.00 ,the lowest forecast is $75.00. The average price target represents 13.49% Increase from the current price of $106.62.
              What do analysts say about Icon plc?
              Icon plc’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 12 Wall Streets Analysts.
                How can I buy shares of ICLR?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.